Paediatric strategy forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients

Date: 05/09/2018 to 06/09/2018
Location: European Medicines Agency, London, UK
The third multi-stakeholder Paediatric Strategy Forum, jointly organised by EMA and ACCELERATE will focus on checkpoint inhibitors used in combination therapy, in children and adolescents. This Forum will reviewed the immunological environment of paediatric malignancies, checkpoint inhibitors in early phase clinical studies in paediatrics, strategies combining checkpoint inhibitors with other products and alternative immunotherapy strategies. Participation is restricted and on invitation only. Interested parties, including patients and parent-representatives, academia, clinicians and industry, should express their interest using the forms linked to this page.

How useful was this page?

Add your rating
Average
3 ratings
5 ratings
6 ratings
4 ratings